查看購物車
  • English
  • Japanese
  • Korean
全球乳房X光攝影系統市場：按產品、最終用戶、地區和國家分類的分析和預測（2026-2036年）
市場調查報告書
商品編碼
2042505

全球乳房X光攝影系統市場：按產品、最終用戶、地區和國家分類的分析和預測（2026-2036年）

Mammography Systems Market - A Global and Regional Analysis: Focus on Product, End User, Regional, and Country Analysis - Analysis and Forecast, 2026-2036
出版日期: | 出版商: BIS Research | 英文 151 Pages | 商品交期: 1-5個工作天內

價格

乳房X光攝影系統市場簡介

全球乳房X光攝影系統市場預計將從2025年的26.63億美元大幅成長至2036年的63.753億美元。這意味著在2026年至2036年期間，其複合年成長率將達到驚人的8.29%。

關鍵市場統計數據
預測期 2026-2036
2026 年評估 28.741億美元
2036 年預測 63.753億美元
複合年成長率 8.29%

乳房X光攝影系統市場的發展動力源自於篩檢、診斷和追蹤護理中對精準、標準化和高品質乳房攝影日益成長的需求。乳房X光攝影仍然是早期發現乳癌的主要影像學方法，並在國家篩檢計畫、醫院放射科、乳房專科中心和門診診斷機構中繼續發揮核心作用。系統設計的不斷進步，透過數位影像擷取、乳房斷層合成、合成2D成像、自動化工作流程支援、劑量管理以及改進的患者定位技術等功能，正將傳統的乳房X光攝影轉變為更有效率、臨床性能更優的平台。這些系統層面的改善在篩檢量大的環境和專業的乳房攝影中心尤其重要，因為在這些場所，診斷的可靠性、檢查的一致性、處理能力和患者舒適度至關重要。

技術創新顯著提升了最新乳房X光攝影系統的性能和易用性。人工智慧影像分析、智慧成像工作流程、增強病灶視覺化、低劑量成像方案以及整合切片檢查引導等技術的發展，有助於提高檢測準確率，同時減少不同檢查者和醫療機構之間的差異。此外，數位乳房斷層合成技術和先進軟體工具的日益普及，拓展了乳房X光攝影系統的應用範圍，使其不再局限於常規篩檢，而是能夠進行更精準的診斷評估，尤其適用於乳房組織緻密的女性。儘管高成本、基礎設施要求、保險報銷的差異以及訓練有素的乳房攝影影像專家資源有限等因素可能會在某些市場限制其普及，但自動化、影像品質和工作流程效率的持續進步有望推動市場長期成長，使乳房X光攝影系統成為現代乳房護理基礎設施的核心組成部分。

就具體產品而言，數位乳房乳房X光攝影系統有望成為主流。

數位乳房X光乳房X光攝影系統之所以佔市場主導地位，是因為它們在臨床接受度、現有基礎設施、成本效益和整個醫療環境中的營運擴充性實現了最佳平衡。隨著世界從類比膠片乳房X光乳房X光攝影過渡到數位乳房X光攝影，數位系統已成為乳癌篩檢和診斷的標準平台，能夠實現更快的影像擷取、透過PACS系統無縫儲存和搜尋，並改善放射科內部的工作流程整合。數位系統之所以被廣泛採用，還在於它們能夠在各種醫療環境中高效運行，包括國家健康篩檢計畫、社區醫院、診斷中心和行動篩檢車，這使得數位系統成為乳房攝影的核心「主流」技術。

此外，與數位乳房斷層合成（DBT）等先進技術相比，數位乳房X光攝影提供了更經濟實惠且更容易取得的解決方案。 DBT等技術需要大量的資金投入、強大的數據處理能力以及更複雜的流程調整。這種成本優勢在預算限制往往阻礙新技術應用的低收入和中等收入醫療系統中尤其重要。此外，由於乳房X光攝影仍然是大多數國家指南中推薦的主要篩檢工具，因此該領域也受益於臨床醫生較高的親和性以及完善的保險報銷機制。這降低了推廣應用的門檻，並促進了其持續使用。

就最終用戶而言，醫院和門診手術中心佔主要地位。

由於醫院和門診手術中心 (ASC) 在綜合醫療保健環境中集中了最多的乳房攝影影像、診斷追蹤和介入手術，因此它們在乳房X光攝影系統市場佔主導地位。這些機構是綜合乳房護理的中心，使患者能夠無縫銜接從篩檢到高級影像檢查、切片檢查、外科會診，以及必要時轉診至腫瘤科。因此，它們是乳房X光攝影系統（包括數位乳房乳房X光攝影和數位乳房斷層合成 (DBT) 等先進技術）最高效且最具商業性價值的終端用戶。

此外，雖然乳房X光攝影系統需要大量的資金投入，包括專用影像室、輻射防護設備、PACS整合以及訓練有素的放射科醫生，但與小規模獨立中心相比，醫院和日間手術中心（ASC）更有能力提供這些服務。它們擁有更雄厚的財力和完善的配套設施，從而推動了這些系統的普及。此外，門診服務、轉診網路和女性健康服務帶來的高病患處理能力顯著提高了設備的使用率，進而提升了這些系統的投資報酬率（ROI）。

醫院尤其受益於來自基層醫療醫生和專科醫生的集中轉診流程，這一趨勢在診斷性乳房X光攝影、緻密乳房評估和癌症篩檢方面尤為顯著，並進一步推動了醫療機構層面設備的採用。同時，隨著乳房攝影和小型手術轉向門診模式，腹部支持協調中心（ASC）的重要性日益凸顯，它能夠提供更快捷、更經濟高效的醫療服務，並減輕住院患者的負擔。

按地區分類，北美處於主導地位。

北美地區正引領著乳房乳房X光攝影系統市場的發展，這得益於多方面因素的共同作用：高水準的系統性篩檢、先進影像技術的早期應用、完善的保險報銷機制以及成熟的醫療基礎設施，這些都加速了技術更新換代的周期。在美國，乳癌篩檢已深度融入臨床實踐，並由聯邦政府監管的、獲得MQSA認證的乳房乳房X光攝影機構提供支援。同時，在加拿大，各省針對平均風險女性實施了系統性或半系統性的篩檢項目，確保了持續穩定的影像檢查需求。此外，該地區高度重視乳癌的早期發現，推動了對數位乳房乳房X光攝影和數位乳房斷層合成（DBT）平台的持續投資。先進技術的應用顯著領先其他地區，DBT已在美國大多數醫療機構廣泛部署。這反映出醫療機構正迅速從標準乳房X光攝影轉向更高價值的影像系統。此外，美國完善的報銷機制和加拿大公共資助的篩檢系統創造了可預測的需求，並支援醫療設備的定期更新。嚴格的品質和法規結構，例如美國的「乳房X光檢查品質標準法案」（MQSA）和加拿大衛生署的標準，進一步強化了這一趨勢，確保了影像品質的一致性，並促進了先進乳房X光攝影系統的廣泛應用。這些因素共同作用，使北美成為全球乳房X光攝影系統市場中最成熟、技術最先進的地區。

本報告分析了全球乳房X光攝影系統市場，總結了關鍵趨勢、市場影響因素、法律制度、市場規模趨勢和預測、按各個細分市場和地區/主要國家進行的詳細分析、競爭格局以及主要公司的概況。

目錄

摘要整理

範圍和定義

第1章：全球乳房X光攝影系統市場：產業展望

  • 市場趨勢
    • 影響分析
    • 從2D系統到3D/DBT系統的快速過渡
  • 監理情勢
    • 美國
    • 歐洲
    • 亞太地區
  • 供應鏈分析
  • 市場動態
    • 促進因素、挑戰和機會：當前和未來影響評估
    • 市場促進因素
    • 市場挑戰
    • 市場機遇

第2章 產品類型

  • 概述
    • 模擬乳房乳房X光攝影系統
    • 數位乳房X光攝影系統

第3章：最終用戶

  • 概述
    • 醫院及門診手術中心
    • 診斷中心
    • 其他最終用戶

第4章 區域

  • 區域概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲
    • 區域概覽
    • 市場成長促進因素
    • 威脅市場的因素
    • 市場規模及預測

第5章：競爭標竿分析與公司概況

  • 全球乳房X光攝影系統市場：關鍵策略與趨勢
  • 主要發展分析（依公司分類）
  • 公司簡介
    • Allengers
    • BMI Biomedical International srl
    • Canon Inc.
    • DMS Group
    • FUJIFILM Corporation
    • GE Healthcare
    • Genoray Co., Ltd
    • Hologic, Inc.
    • IMS Giotto SpA
    • Metaltronica SpA
    • Planmed Oy
    • Siemens Healthineers
    • Shanghai United Imaging Healthcare Co., LTD
    • Trivitron Healthcare
    • Villa Sistemi Medicali SPA

第6章：調查方法

Product Code: BHR0664SB

This report can be delivered within 1 working day.

Introduction of the Mammography Systems Market

The global mammography systems market, initially valued at $2,663.0 million in 2025, is projected to witness substantial growth, reaching $6,375.3 million by 2036, marking a remarkable compound annual growth rate (CAGR) of 8.29% over the period from 2026 to 2036.

KEY MARKET STATISTICS
Forecast Period2026 - 2036
2026 Evaluation$2,874.1 Million
2036 Forecast$6,375.3 Million
CAGR8.29%

The mammography systems market is being shaped by the growing need for accurate, standardized, and high-quality breast imaging across screening, diagnostic, and follow-up care settings. Mammography remains the primary imaging modality for early breast cancer detection and continues to play a central role in national screening programs, hospital radiology departments, dedicated breast centers, and outpatient diagnostic facilities. Ongoing advances in system design are transforming conventional mammography into a more efficient and clinically capable platform through features such as digital image acquisition, breast tomosynthesis, synthesized 2D imaging, automated workflow support, dose management, and improved patient-positioning technologies. These system-level improvements are particularly valuable in high-volume screening environments and specialist breast imaging practices, where diagnostic confidence, exam consistency, throughput, and patient comfort are critical.

Technological innovation is significantly enhancing the performance and usability of modern mammography systems. Developments such as AI-assisted image analysis, intelligent acquisition workflows, enhanced lesion visualization, low-dose imaging protocols, and integrated biopsy guidance are helping improve detection accuracy while reducing variability across operators and sites. In addition, the increasing use of digital breast tomosynthesis and advanced software tools is expanding the role of mammography systems beyond routine screening into more precise diagnostic assessment, especially in women with dense breast tissue. Although high equipment costs, infrastructure requirements, reimbursement variability, and limited access to trained breast imaging specialists may constrain adoption in some markets, continued progress in automation, image quality, and workflow efficiency is expected to support long-term market growth, positioning mammography systems as a core component of modern breast care infrastructure.

Market Introduction

The global mammography systems market is evolving steadily as healthcare systems place increasing emphasis on early detection and improved diagnostic accuracy for breast cancer, the most commonly diagnosed cancer among women worldwide. Mammography continues to serve as the primary imaging modality for breast cancer screening and diagnosis, forming the backbone of both organized population-based screening programs and opportunistic diagnostic pathways. The market is witnessing a transition from conventional analog systems to advanced digital mammography and digital breast tomosynthesis (DBT) platforms, driven by the need for higher image clarity, better lesion detection particularly in dense breast tissue and improved workflow efficiency in high-volume clinical environments.

Continuous technological advancements are reshaping modern mammography systems, with innovations focused on 2D/3D hybrid imaging, DBT integration, and AI-assisted image interpretation. These developments are enhancing diagnostic confidence, reducing recall rates, and supporting radiologists in managing increasing screening volumes with greater efficiency. The growing adoption of integrated imaging platforms that combine mammography with advanced software, PACS connectivity, and automated quality control is further improving operational consistency across healthcare facilities. Although adoption varies across regions depending on infrastructure maturity and reimbursement frameworks, the strong clinical need for early detection, coupled with rising awareness and expanding screening initiatives, is expected to support sustained long-term growth of the mammography systems market globally.

Industrial Impact

The global mammography systems market is having significant impact on the breast imaging industry by driving the transition toward more advanced, digital, and clinically integrated breast care platforms. Major companies such as Hologic, Inc., GE HealthCare, Siemens Healthineers, FUJIFILM, Canon Medical Systems, Planmed Oy, and Metaltronica are continuously enhancing mammography systems with capabilities such as digital breast tomosynthesis, synthesized 2D imaging, dose optimization, biopsy integration, and AI-supported workflow tools. These advancements are particularly important in breast screening programs, oncology centers, women's health clinics, and diagnostic imaging departments, where image quality, reading efficiency, and early lesion detection are critical. As a result, mammography systems are moving beyond their traditional role as standalone screening devices and becoming central components of more comprehensive breast imaging pathways.

Moreover, ongoing innovation in mammography systems is reshaping purchasing priorities, service models, and technology competition across the medical imaging sector. Healthcare providers are increasingly evaluating systems not only on image acquisition performance, but also on workflow speed, patient comfort, interoperability, and compatibility with advanced applications such as tomosynthesis-guided biopsy and AI-assisted image interpretation. This is encouraging manufacturers to develop more intelligent, ergonomic, and scalable platforms that can support both high-volume screening and complex diagnostic workflows. At the same time, growing demand for early cancer detection, expansion of breast imaging services, and replacement of aging analog or first-generation digital units are supporting long-term market momentum. By improving diagnostic confidence, enabling more efficient breast care delivery, and strengthening the infrastructure for population screening and personalized diagnosis, mammography systems are playing an increasingly important role in the evolution of modern women's healthcare.

Market Segmentation:

Segmentation 1: By Product

  • Analog Mammography Systems
  • Digital Mammography Systems

Digital Mammography Systems Segment to Dominate the Mammography Systems Market (by Product)

Digital mammography systems dominate the market as they represent the most balanced combination of clinical acceptance, installed infrastructure, cost efficiency, and operational scalability across healthcare settings. Following the global transition from analog film-based mammography, digital systems became the default platform for breast cancer screening and diagnosis, enabling faster image acquisition, seamless storage and retrieval via PACS, and improved workflow integration within radiology departments. Their widespread adoption is further reinforced by their ability to function effectively across diverse care environments, including national screening programs, community hospitals, diagnostic centers, and mobile screening units, making them the core "workhorse" technology of breast imaging.

In addition, digital mammography offers a more affordable and accessible solution compared to advanced modalities such as DBT, which require higher capital investment, greater data handling capacity, and more complex workflow adjustments. This cost advantage is particularly important in mid- and low-resource healthcare systems, where budget constraints limit rapid adoption of newer technologies. The segment also benefits from strong clinician familiarity and established reimbursement frameworks, as mammography remains the primary recommended screening tool in most national guidelines, reducing adoption barriers and supporting consistent utilization.

Segmentation 2: By End User

  • Hospitals and Ambulatory Surgical Centers
  • Diagnostics Center
  • Other End User

Hospitals and Ambulatory Surgical Centers Segment to Dominate the Mammography Systems Market (by End User)

Hospitals and ambulatory surgical centers (ASCs) dominate the mammography systems market because they concentrate the highest volume of breast imaging, diagnostic follow-ups, and interventional procedures within integrated care settings. These facilities function as complete breast-care hubs, where patients can move seamlessly from screening to advanced imaging, biopsy, surgical consultation, and oncology referral when required, making them the most efficient and commercially viable end users for mammography systems, including advanced technologies such as digital mammography and DBT.

They also lead adoption due to their stronger financial capacity and supporting infrastructure, as mammography systems require significant capital investment, dedicated imaging suites, radiation shielding, PACS integration, and trained radiology personnel resources that hospitals and ASCs are better equipped to provide compared with smaller standalone centers. In addition, high patient throughput driven by outpatient clinics, referral networks, and women's health services ensures strong equipment utilization rates, improving return on investment for these systems.

Hospitals, in particular, benefit from centralized referral flows from primary care physicians and specialists, especially for diagnostic mammography, dense-breast evaluation, and cancer workups, which further reinforces equipment adoption at the institutional level. Meanwhile, ASCs are increasingly important as breast imaging and minor procedures shift toward outpatient models, enabling faster, cost-efficient care delivery and reducing inpatient burden.

Segmentation 3: By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest-of-Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest-of-Latin America
  • Middle East and Africa

North America to Dominate the Mammography Systems Market (by Region)

North America dominates the mammography systems market due to its combination of high and structured screening volumes, early adoption of advanced imaging technologies, strong reimbursement frameworks, and mature healthcare infrastructure that enables rapid technology replacement cycles. In the U.S., breast cancer screening is deeply integrated into clinical practice and supported by federally regulated MQSA-certified mammography facilities, while Canada operates organized or semi-organized screening programs across all provinces for average-risk women, ensuring consistent and recurring imaging demand. The region also maintains a strong public health emphasis on early breast cancer detection, driving continuous investment in both digital mammography and digital breast tomosynthesis (DBT) platforms. Adoption of advanced technologies is significantly ahead of other regions, with DBT already widely deployed across a majority of U.S. facilities, reflecting faster conversion from standard mammography to higher-value imaging systems. Additionally, well-established reimbursement systems in the U.S. and publicly funded screening structures in Canada create predictable demand and support regular capital equipment upgrades. This is further reinforced by stringent quality and regulatory frameworks, such as MQSA in the U.S. and Health Canada standards, which ensure consistent imaging quality and facilitate large-scale deployment of advanced mammography systems. Together, these factors position North America as the most mature and technologically advanced region in the global mammography systems market.

Recent Developments in the Mammography Systems Market

  • In November 2025, GE HealthCare received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Leveraging deep learning, this innovation enhances image clarity and sharpness, setting a new benchmark in mammography imaging quality.
  • In November 2025, At the 2025 Radiological Society of North America Annual Meeting, Siemens Healthineers unveiled enhanced capabilities for its Mammomat B.brilliant mammography system, strengthening both contrast-enhanced imaging and biopsy functions. The system, which already delivers high-resolution 3D breast images using wide-angle tomosynthesis in just five seconds, will now also incorporate a newly developed image reconstruction technique to further improve contrast-enhanced examinations.
  • In May 2025, Siemens Healthineers has introduced the MAMMOMAT B.brilliant in Indonesia, a next-generation mammography system designed to enhance breast imaging capabilities.
  • In November 2024, GE HealthCare introduced the new Pristina Via mammography system, created to improve the screening experience for both technologists and patients.

Demand - Drivers, Challenges, and Opportunities

Market Drivers:

Increasing Incidence of Breast Cancer: The increasing incidence of breast cancer is one of the major factors driving the demand for mammography systems across the world. According to Breastcancer.org, breast cancer is currently the most common cancer among women worldwide, with approximately 2.3 million new cases reported globally in 2023, accounting for one in four cancers among women. In addition, as per the study titled "Global, regional, and national burden of breast cancer among females, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023" published by The Lancet Oncology in March 2026, the global number of new breast cancer cases is expected to increase by about one-third, rising from 2.3 million in 2023 to more than 3.5 million by 2050. Meanwhile, annual deaths from breast cancer worldwide are projected to grow by 44%, climbing from 764,000 to nearly 1.4 million by 2050

This upward trend is evident across both developed and developing regions. The high-income regions, such as North America, Northern Europe, Australia, and New Zealand, report the highest incidence rates, driven by lifestyle factors and robust screening programs that enable greater detection. In contrast, low- and middle-income regions, particularly Western Africa and parts of Oceania, experience disproportionately high mortality rates due to limited access to early screening and treatment. According to the data published by the World Health Organization in February 2025, in countries with very high Human Development Index (HDI), approximately 17 out of 100 women diagnosed with breast cancer die from the disease, whereas in low-HDI countries, more than 56 out of 100 women diagnosed do not survive, highlighting significant gaps in early screening and healthcare access. This has raised the demand for mammography systems.

Market Challenges:

Shortage of Trained Professionals: A key restraint for the mammography systems market is the global shortage of trained radiologists and mammography technologists, which limits the effective utilization of installed imaging infrastructure. While demand for breast imaging continues to rise, the supply of skilled professionals required to acquire, interpret, and report mammography results has not kept pace, creating a structural imbalance where diagnostic capacity is constrained by workforce availability rather than equipment supply. As a result, many healthcare systems face underutilization of advanced mammography assets despite growing screening volumes.

This gap is particularly evident in the United States. According to a February 2026 report by Medicus Healthcare Solutions, approximately 7,500 breast imaging radiologists are responsible for a screening population of nearly 130 million women aged 40 and above, equating to roughly four specialists per 100,000 women. The challenge has been further intensified following the U.S. Preventive Services Task Force's decision in 2024 to lower the recommended screening age from 50 to 40, which added an estimated 20 million additional eligible women for screening. However, radiologist workforce expansion has not kept pace with this increase in demand, widening the gap between screening requirements and diagnostic capacity and placing sustained pressure on mammography service delivery.

Market Opportunities:

Untapped Market Opportunity for Mammography Systems in Emerging Economies: Emerging economies represent a significant growth opportunity for the mammography systems market, driven by the rising global burden of breast cancer and substantial gaps in screening access and diagnostic infrastructure. Many low- and middle-income countries continue to face limited availability of mammography equipment, uneven healthcare distribution, and low screening participation rates, resulting in delayed diagnoses and higher mortality outcomes. As a result, governments in countries such as India, Indonesia, and South Africa are increasingly prioritizing population-based screening initiatives and investing in diagnostic imaging capacity, which is expected to accelerate the adoption of mammography systems over time.

Evidence from Latin America further highlights these structural gaps, where screening coverage remains uneven and generally ranges between 20% and 60% across countries. For instance, in Mexico, effective screening coverage is below 25%, while Peru reports rates of approximately 23-25%, falling further in rural and uninsured populations. Similarly, in countries such as Chile and Brazil, women from lower-income groups are significantly less likely to undergo regular screening, reflecting strong socioeconomic disparities in access to early detection services. Geographic imbalances also persist, with Brazil showing heavy concentration of mammography infrastructure in developed urban regions, while rural areas remain underserved, and Peru demonstrating substantially lower screening access in rural populations compared to urban centers. Collectively, these disparities underscore a large unmet clinical need and position emerging markets as high-potential regions for long-term mammography system expansion.

How can this report add value to an organization?

Growth/Marketing Strategy: Strategic partnerships, public-private collaborations, and geographic expansion are key growth levers in the mammography systems market. OEMs are increasingly targeting hospital networks, diagnostic chains, and government screening programs, while also focusing on emerging markets to address unmet screening demand. Expansion into mobile screening units, retrofit upgrades from analog to digital systems, and integration with national breast cancer screening initiatives are enabling wider adoption and penetration into under-served regions.

Competitive Strategy: The mammography systems market is highly competitive, with leading OEMs focusing on technological differentiation through advanced imaging performance, AI-assisted diagnostics, and workflow efficiency. Companies are increasingly competing on integrated solutions that combine hardware, software, and analytics to reduce radiologist workload and improve diagnostic consistency. Competitive advantage is increasingly defined by clinical accuracy, ease of use, interoperability with hospital systems, and the ability to support high-volume screening environments.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • Years from 2024 to 2036 have been considered for the global market size estimation, 2025 has been considered as the base year, and 2026 to 2036 as the forecast period.
  • The scope of the report is based on comprehensive inputs from industry experts across various sectors, including hospitals, diagnostic laboratories, imaging centers, and research institutions.
  • The market contribution of mammography systems is anticipated to grow substantially in the future, with projections based on historical analysis of available solutions.
  • Revenues from companies have been sourced from their annual reports for FY2024 and FY2025. For private companies, revenue estimates are derived from primary research inputs, funding history, market collaborations, and operational performance.
  • The market has been mapped based on the existing mammography systems. Key companies with significant offerings in this field have been identified and profiled in this report.

Primary Research

The primary sources involve industry experts and key stakeholders across the healthcare and radiography ecosystem, including mammography manufacturers (OEMs), medical device companies, radiology service providers, and healthcare institutions. Stakeholders such as hospitals, imaging centers, and screening programs have been consulted to validate adoption trends, system-level integration, and clinical utility specific to mammography systems. Respondents, including CEOs, vice presidents, product and marketing directors, and technology and innovation leaders, have been interviewed to obtain and verify both qualitative and quantitative insights for this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of report segmentations and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investors' presentations of the leading market players
  • Company websites and a detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players in the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Allengers
  • BMI Biomedical International s.r.l
  • Canon Inc.
  • DMS Group
  • FUJIFILM Corporation
  • GE Healthcare
  • Genoray Co., Ltd.
  • Hologic, Inc.
  • IMS Giotto S.p.A.
  • Metaltronica S.p.A.
  • Planmed Oy
  • Siemens Healthineers
  • Shanghai United Imaging Healthcare Co., Ltd.
  • Trivitron Healthcare
  • VillaSistemi Medicali S.p.A.

Table of Contents

Executive Summary

Scope and Definition

1 Global Mammography Systems Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Impact Analysis
    • 1.1.2 Rapid Shift from 2D to 3D/DBT Systems
  • 1.2 Regulatory Landscape
    • 1.2.1 U.S.
    • 1.2.2 Europe
    • 1.2.3 Asia-Pacific
      • 1.2.3.1 China
      • 1.2.3.2 Japan
  • 1.3 Supply Chain Analysis
  • 1.4 Market Dynamics
    • 1.4.1 Drivers, Challenges, and Opportunities: Current and Future Impact Assessment
    • 1.4.2 Market Drivers
      • 1.4.2.1 Increasing Incidence of Breast Cancer
      • 1.4.2.2 Growing Government Screening Initiatives and Policy Mandates Supporting Mammography Adoption
      • 1.4.2.3 Upsurge in Aging Population Increases Demand for Mammography Screening
      • 1.4.2.4 Expansion of Women's Health Centers
    • 1.4.3 Market Challenges
      • 1.4.3.1 High Capital and Maintenance Cost
      • 1.4.3.2 Shortage of Trained Professionals
    • 1.4.4 Market Opportunities
      • 1.4.4.1 Untapped Market Opportunity for Mammography Systems in Emerging Economies

2 Product Type

  • 2.1 Overview
    • 2.1.1 Analog Mammography Systems
    • 2.1.2 Digital Mammography Systems

3 End User

  • 3.1 Overview
    • 3.1.1 Hospitals and Ambulatory Surgical Centers
    • 3.1.2 Diagnostics Centers
    • 3.1.3 Other End Users

4 Region

  • 4.1 Regional Summary
  • 4.2 North America
    • 4.2.1 Regional Overview
    • 4.2.2 Driving Factors for Market Growth
    • 4.2.3 Factors Challenging the Market
    • 4.2.4 Market Sizing and Forecast
      • 4.2.4.1 U.S.
        • 4.2.4.1.1 Country Overview
        • 4.2.4.1.2 Driving Factors for Market Growth
        • 4.2.4.1.3 Factors Challenging the Market
        • 4.2.4.1.4 Market Sizing and Forecast
      • 4.2.4.2 Canada
        • 4.2.4.2.1 Country Overview
        • 4.2.4.2.2 Driving Factors for Market Growth
        • 4.2.4.2.3 Factors Challenging the Market
        • 4.2.4.2.4 Market Sizing and Forecast
  • 4.3 Europe
    • 4.3.1 Regional Overview
    • 4.3.2 Driving Factors for Market Growth
    • 4.3.3 Factors Challenging the Market
    • 4.3.4 Market Sizing and Forecast
      • 4.3.4.1 U.K.
        • 4.3.4.1.1 Country Overview
        • 4.3.4.1.2 Driving Factors for Market Growth
        • 4.3.4.1.3 Factors Challenging the Market
        • 4.3.4.1.4 Market Sizing and Forecast
      • 4.3.4.2 Germany
        • 4.3.4.2.1 Country Overview
        • 4.3.4.2.2 Driving Factors for Market Growth
        • 4.3.4.2.3 Factors Challenging the Market
        • 4.3.4.2.4 Market Sizing and Forecast
      • 4.3.4.3 France
        • 4.3.4.3.1 Country Overview
        • 4.3.4.3.2 Driving Factors for Market Growth
        • 4.3.4.3.3 Factors Challenging the Market
        • 4.3.4.3.4 Market Sizing and Forecast
      • 4.3.4.4 Italy
        • 4.3.4.4.1 Country Overview
        • 4.3.4.4.2 Driving Factors for Market Growth
        • 4.3.4.4.3 Factors Challenging the Market
        • 4.3.4.4.4 Market Sizing and Forecast
      • 4.3.4.5 Spain
        • 4.3.4.5.1 Country Overview
        • 4.3.4.5.2 Driving Factors for Market Growth
        • 4.3.4.5.3 Factors Challenging the Market
        • 4.3.4.5.4 Market Sizing and Forecast
      • 4.3.4.6 Rest-of-the- Europe
        • 4.3.4.6.1 Country Overview
        • 4.3.4.6.2 Driving Factors for Market Growth
        • 4.3.4.6.3 Factors Challenging the Market
        • 4.3.4.6.4 Market Sizing and Forecast
  • 4.4 Asia Pacific
    • 4.4.1 Regional Overview
    • 4.4.2 Driving Factors for Market Growth
    • 4.4.3 Factors Challenging the Market
    • 4.4.4 Market Sizing and Forecast
      • 4.4.4.1 China
        • 4.4.4.1.1 Country Overview
        • 4.4.4.1.2 Driving Factors for Market Growth
        • 4.4.4.1.3 Factors Challenging the Market
        • 4.4.4.1.4 Market Sizing and Forecast
      • 4.4.4.2 Japan
        • 4.4.4.2.1 Country Overview
        • 4.4.4.2.2 Driving Factors for Market Growth
        • 4.4.4.2.3 Factors Challenging the Market
        • 4.4.4.2.4 Market Sizing and Forecast
      • 4.4.4.3 India
        • 4.4.4.3.1 Country Overview
        • 4.4.4.3.2 Driving Factors for Market Growth
        • 4.4.4.3.3 Factors Challenging the Market
        • 4.4.4.3.4 Market Sizing and Forecast
      • 4.4.4.4 Australia
        • 4.4.4.4.1 Country Overview
        • 4.4.4.4.2 Driving Factors for Market Growth
        • 4.4.4.4.3 Factors Challenging the Market
        • 4.4.4.4.4 Market Sizing and Forecast
      • 4.4.4.5 South Korea
        • 4.4.4.5.1 Country Overview
        • 4.4.4.5.2 Driving Factors for Market Growth
        • 4.4.4.5.3 Factors Challenging the Market
        • 4.4.4.5.4 Market Sizing and Forecast
      • 4.4.4.6 Rest-of-the-Asia Pacific
        • 4.4.4.6.1 Country Overview
        • 4.4.4.6.2 Driving Factors for Market Growth
        • 4.4.4.6.3 Factors Challenging the Market
        • 4.4.4.6.4 Market Sizing and Forecast
  • 4.5 Latin America
    • 4.5.1 Regional Overview
    • 4.5.2 Driving Factors for Market Growth
    • 4.5.3 Factors Challenging the Market
    • 4.5.4 Market Sizing and Forecast
      • 4.5.4.1 Brazil
        • 4.5.4.1.1 Country Overview
        • 4.5.4.1.2 Driving Factors for Market Growth
        • 4.5.4.1.3 Factors Challenging the Market
        • 4.5.4.1.4 Market Sizing and Forecast
      • 4.5.4.2 Mexico
        • 4.5.4.2.1 Country Overview
        • 4.5.4.2.2 Driving Factors for Market Growth
        • 4.5.4.2.3 Factors Challenging the Market
        • 4.5.4.2.4 Market Sizing and Forecast
      • 4.5.4.3 Rest-of-Latin America
        • 4.5.4.3.1 Country Overview
        • 4.5.4.3.2 Driving Factors for Market Growth
        • 4.5.4.3.3 Factors Challenging the Market
        • 4.5.4.3.4 Market Sizing and Forecast
  • 4.6 Middle-East & Africa
    • 4.6.1 Regional Overview
    • 4.6.2 Driving Factors for Market Growth
    • 4.6.3 Factors Challenging the Market
    • 4.6.4 Market Sizing and Forecast

5 Competitive Benchmarking and Company Profiles

  • 5.1 Global Mammography Systems Market, Key Strategies and Developments, January 2023-March 2026
  • 5.2 Key Developments Analysis (by Company), January 2023-March 2026
  • 5.3 Company Profiles
    • 5.3.1 Allengers
      • 5.3.1.1 Overview
      • 5.3.1.2 Top Products
      • 5.3.1.3 Top Competitors
      • 5.3.1.4 Key Personnel
      • 5.3.1.5 Analyst View
    • 5.3.2 BMI Biomedical International s.r.l.
      • 5.3.2.1 Overview
      • 5.3.2.2 Top Products
      • 5.3.2.3 Top Competitors
      • 5.3.2.4 Key Personnel
      • 5.3.2.5 Analyst View
    • 5.3.3 Canon Inc.
      • 5.3.3.1 Overview
      • 5.3.3.2 Top Products
      • 5.3.3.3 Top Competitors
      • 5.3.3.4 Key Personnel
      • 5.3.3.5 Analyst View
    • 5.3.4 DMS Group
      • 5.3.4.1 Overview
      • 5.3.4.2 Top Products
      • 5.3.4.3 Top Competitors
      • 5.3.4.4 Key Personnel
      • 5.3.4.5 Analyst View
    • 5.3.5 FUJIFILM Corporation
      • 5.3.5.1 Overview
      • 5.3.5.2 Top Products
      • 5.3.5.3 Top Competitors
      • 5.3.5.4 Key Personnel
      • 5.3.5.5 Analyst View
    • 5.3.6 GE Healthcare
      • 5.3.6.1 Overview
      • 5.3.6.2 Top Products
      • 5.3.6.3 Top Competitors
      • 5.3.6.4 Key Personnel
      • 5.3.6.5 Analyst View
    • 5.3.7 Genoray Co., Ltd
      • 5.3.7.1 Overview
      • 5.3.7.2 Top Products
      • 5.3.7.3 Top Competitors
      • 5.3.7.4 Key Personnel
      • 5.3.7.5 Analyst View
    • 5.3.8 Hologic, Inc.
      • 5.3.8.1 Overview
      • 5.3.8.2 Top Products
      • 5.3.8.3 Top Competitors
      • 5.3.8.4 Key Personnel
      • 5.3.8.5 Analyst View
    • 5.3.9 IMS Giotto S.p.A
      • 5.3.9.1 Overview
      • 5.3.9.2 Top Products
      • 5.3.9.3 Top Competitors
      • 5.3.9.4 Key Personnel
      • 5.3.9.5 Analyst View
    • 5.3.10 Metaltronica S.p.A.
      • 5.3.10.1 Overview
      • 5.3.10.2 Top Products
      • 5.3.10.3 Top Competitors
      • 5.3.10.4 Key Personnel
      • 5.3.10.5 Analyst View
    • 5.3.11 Planmed Oy
      • 5.3.11.1 Overview
      • 5.3.11.2 Top Products
      • 5.3.11.3 Top Competitors
      • 5.3.11.4 Key Personnel
      • 5.3.11.5 Analyst View
    • 5.3.12 Siemens Healthineers
      • 5.3.12.1 Overview
      • 5.3.12.2 Top Products
      • 5.3.12.3 Top Competitors
      • 5.3.12.4 Key Personnel
      • 5.3.12.5 Analyst View
    • 5.3.13 Shanghai United Imaging Healthcare Co., LTD
      • 5.3.13.1 Overview
      • 5.3.13.2 Top Products
      • 5.3.13.3 Top Competitors
      • 5.3.13.4 Key Personnel
      • 5.3.13.5 Analyst View
    • 5.3.14 Trivitron Healthcare
      • 5.3.14.1 Overview
      • 5.3.14.2 Top Products
      • 5.3.14.3 Top Competitors
      • 5.3.14.4 Key Personnel
      • 5.3.14.5 Analyst View
    • 5.3.15 Villa Sistemi Medicali S.P.A.
      • 5.3.15.1 Overview
      • 5.3.15.2 Top Products
      • 5.3.15.3 Top Competitors
      • 5.3.15.4 Key Personnel
      • 5.3.15.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global Mammography Systems Market (by Scenario), $Million, 2025, 2026, and 2036
  • Figure 2: Global Mammography Systems Market, 2025 and 2036
  • Figure 3: Global Mammography Systems Market (by Country), $Million, 2025
  • Figure 4: Global Mammography Systems Market Snapshot
  • Figure 5: Global Mammography Systems Market, $Million, 2025 and 2036
  • Figure 6: Mammography Systems Market (by Product), $Million, 2025, 2028, and 2036
  • Figure 7: Mammography Systems Market (by End User), $Million, 2025, 2030, and 2036
  • Figure 8: Supply Chain Analysis for the Global Mammography Systems Market
  • Figure 9: Global Mammography Systems Market (by Product Type), $Million, 2025, 2029, and 2036
  • Figure 10: Global Mammography Systems Market (Analog Mammography Systems), $Million, 2024-2036
  • Figure 11: Global Mammography Systems Market (Digital Mammography Systems), $Million, 2024-2036
  • Figure 12: Global Mammography Systems Market (by End User), $Million, 2025, 2029, and 2036
  • Figure 13: Global Mammography Systems Market (Hospitals and Ambulatory Surgical Centers), $Million, 2024-2036
  • Figure 14: Global Mammography Systems Market (Diagnostics Centers), $Million, 2024-2036
  • Figure 15: Global Mammography Systems Market (Other End Users), $Million, 2024-2036
  • Figure 16: North America Mammography Systems Market, $Million, 2024-2036
  • Figure 17: U.S. Mammography Systems Market, $Million, 2024-2036
  • Figure 18: Canada Mammography Systems Market, $Million, 2024-2036
  • Figure 19: Europe Mammography Systems Market, $Million, 2024-2036
  • Figure 20: U.K. Mammography Systems Market, $Million, 2024-2036
  • Figure 21: Germany Mammography Systems Market, $Million, 2024-2036
  • Figure 22: France Mammography Systems Market, $Million, 2024-2036
  • Figure 23: Italy Mammography Systems Market, $Million, 2024-2036
  • Figure 24: Spain Mammography Systems Market, $Million, 2024-2036
  • Figure 25: Rest-of-Europe Mammography Systems Market, $Million, 2024-2036
  • Figure 26: Asia-Pacific Mammography Systems Market, $Million, 2024-2036
  • Figure 27: China Mammography Systems Market, $Million, 2024-2036
  • Figure 28: Japan Mammography Systems Market, $Million, 2024-2036
  • Figure 29: India Mammography Systems Market, $Million, 2024-2036
  • Figure 30: Australia Mammography Systems Market, $Million, 2024-2036
  • Figure 31: South Korea Mammography Systems Market, $Million, 2024-2036
  • Figure 32: Rest-of-Asia-Pacific Mammography Systems Market, $Million, 2024-2036
  • Figure 33: Latin America Mammography Systems Market, $Million, 2024-2036
  • Figure 34: Brazil Mammography Systems Market, $Million, 2024-2036
  • Figure 35: Mexico Mammography Systems Market, $Million, 2024-2036
  • Figure 36: Rest-of- Latin America Mammography Systems Market, $Million, 2024-2036
  • Figure 37: Middle East and Africa Mammography Systems Market, $Million, 2024-2036
  • Figure 38: Global Mammography Systems Market, Key Strategies and Developments, January 2023-March 2026
  • Figure 39: Data Triangulation
  • Figure 40: Top-Down and Bottom-Up Approach
  • Figure 41: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Medical Device Classification as Per MDR
  • Table 3: Mammography Systems Classification
  • Table 4: Regulatory Landscape for Mammography Devices Across Key Asia-Pacific Markets
  • Table 5: Breast Cancer Incidence, 2020-2023, by Country
  • Table 6: Cost of Mammography Systems
  • Table 7: Operational Expenses of Mammography Systems
  • Table 8: Global Mammography Systems Market (by Region), $Million, 2024-2036
  • Table 9: North America Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 10: North America Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 11: U.S. Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 12: U.S. Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 13: Canada Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 14: Canada Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 15: Europe Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 16: Europe Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 17: U.K. Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 18: U.K. Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 19: Germany Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 20: Germany Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 21: France Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 22: France Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 23: Italy Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 24: Italy Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 25: Spain Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 26: Spain Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 27: Rest-of-Europe Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 28: Rest-of-Europe Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 29: Asia-Pacific Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 30: Asia Pacific Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 31: China Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 32: China Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 33: Japan Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 34: Japan Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 35: India Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 36: India Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 37: Australia Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 38: Australia Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 39: South Korea Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 40: South Korea Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 41: Rest-of-Asia-Pacific Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 42: Rest-of-Asia-Pacific Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 43: Latin America Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 44: Latin America Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 45: Brazil Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 46: Brazil Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 47: Mexico Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 48: Mexico Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 49: Rest-of-Latin America Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 50: Rest-of-Latin America Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 51: Middle East and Africa Mammography Systems Market (by Product Type), $Million, 2024-2036
  • Table 52: Middle East and Africa Mammography Systems Market (End Users), $Million, 2024-2036
  • Table 53: Global Mammography Systems Market, Key Strategies and Developments (by Company), January 2023-March 2026